CD274 and neoplasm: Using immunohistochemistry to evaluate PD-L1 expression in tumor cells from urinary samples assembled as UCBs can overcome the limitations of traditional methods like enzyme-linked immunosorbent assay (ELISA) analysis toll, due to the complexity of urine composition.